Macopharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.11 M
- Company Age 44 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.37 Cr
- Revenue Growth 24.40%
- Profit Growth 68.85%
- Ebitda 173.63%
- Net Worth 33.42%
- Total Assets 14.15%
About Macopharma
Macopharma Pvt Ltd (MPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 April 1980 and has a history of 44 years and nine months. Its registered office is in Raigad, Maharashtra.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.11 M.
The company currently has active open charges totaling ₹1.37 Cr.
Vidya Karkun and Anannya Joshi serve as directors at the Company.
Company Details
- LocationRaigad, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U29297MH1980PTC022500
- Company No.
022500
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 1980
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Macopharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vidya Karkun  | Director | 01-Sep-2003 | Current |
| Anannya Joshi | Director | 03-Nov-2020 | Current |
Financial Performance of Macopharma.
Macopharma Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 24.4% increase. The company also saw a substantial improvement in profitability, with a 68.85% increase in profit. The company's net worth Soared by an impressive increase of 33.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Macopharma?
In 2021, Macopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹13.70 M
₹0
Charges Breakdown by Lending Institutions
- The Shamrao Vithal Co-Op. Bank Ltd. : 0.90 Cr
- Industrial Development Bank Of India : 0.28 Cr
- The United Western Bank Ltd : 0.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 May 2008 | The Shamrao Vithal Co-Op. Bank Ltd. | ₹4.50 M | Open |
| 17 Apr 2008 | The Shamrao Vithal Co-Op. Bank Ltd. | ₹4.50 M | Open |
| 19 Oct 2006 | Industrial Development Bank Of India | ₹0.30 M | Open |
| 19 Oct 2006 | Industrial Development Bank Of India | ₹2.50 M | Open |
| 29 Mar 2005 | The United Western Bank Ltd | ₹0.70 M | Open |
How Many Employees Work at Macopharma?
Unlock and access historical data on people associated with Macopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Macopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Macopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
